Barely Significant
← all excerpts

Tegoprazan dual and quadruple therapy for <i>Helicobacter pylori</i> eradication: a prospective, randomized controlled trial in Beijing, China.

Front Med (Lausanne) · 2025 · PMC12378760 · PMID 40873796

Europe PMCDOI
1
hedged sentence
0.0590
closest p · 1.2× alpha
0.0590
boldest claim

The sentences

approached significancep = 0.059so close (0.05 < p ≤ 0.1)
Statistical comparisons revealed that TBQT significantly outperformed BQT ( p = 0.039), while TAD approached significance compared to BQT ( p = 0.059).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.